NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Serum Institute of India in Talks to Expand MyLab Discovery Solutions Internationally

Mumbai: The Serum Institute of India Pvt. Ltd, led by Adar Poonawalla, is in discussions with medical device maker Trivitron Healthcare to form a partnership. This potential alliance aims to increase the investment in MyLab Discovery Solutions Pvt. Ltd, a diagnostics provider based in Pune.

According to three individuals familiar with the matter, the partnership will enable Serum Institute of India to expand MyLab Discovery Solutions' operations on a global scale. While further details on the proposed partnership are not yet available, the move is seen as a strategic move to increase the reach of the diagnostics provider.

The Serum Institute of India, led by Adar Poonawalla, is one of the largest vaccine manufacturers in the world, and this move is expected to bolster the company's presence in the diagnostics sector. The partnership with Trivitron Healthcare will likely have a significant impact on the global diagnostics market, with MyLab Discovery Solutions expanding its operations into new territories.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

CompanyCurrent StatusProposed Expansion
MyLab Discovery Solutions Pvt. LtdCurrently operational in IndiaExpected to expand internationally

Note: The table above highlights the current status and proposed expansion of MyLab Discovery Solutions Pvt. Ltd. The exact details of the expansion are not yet available.

Investor Takeaway

Investors should keep an eye on the potential expansion of MyLab Discovery Solutions globally.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.